Back

The safety and efficacy of etanercept on cardiac functions and lipid profile in patients with active rheumatoid arthritis

29 August 2016 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 5 - Valvular disease Valvular heart disease, other ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Mehmet Gungor Kaya

Erciyes University, Kayseri (Turkiye)

26 More presentations in this session

Presentation thumbnail
Doctor K. Nagao (Kyoto, JP)
Abstract
Presentation thumbnail
Doctor E. Wypasek (Cracow, PL)
Abstract Slides
Presentation thumbnail
Doctor P. Balagny (Paris, FR)
Abstract Slides
Presentation thumbnail
Doctor J. Lopez Aguilera (Cordoba, ES)
Abstract Slides
Presentation thumbnail
Doctor A. Mateescu (Bucharest, RO)
Abstract Slides

Access the full session

Session thumbnail
Poster session 5 - Valvular disease

The Event

Event poster

ESC Congress 2016

29 August 2016 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Case 2: immune-mediated rheumatologic diseases and cardiovascular involvement
30 August 2025
thumbnail
Congress Presentation
Psoriatic arthritis: changes in size, shape and function of the heart
29 June 2021
thumbnail
Webinar
How to organise cardiovascular monitoring during cancer treatment: who, when and how. ESC 2022 Clinical Practice Guidelines - Webinar Series
26 September 2022
thumbnail
Congress Presentation
The correlation between inflammatory biomarker and ejection fraction, and their evolution under the treatment with nebivolol vs bisoprolol in patients undergoing coronary angioplasty
2 March 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources